In this episode, we speak with Dr. Atul Gupta, a professor at the Wharton School, about the role of free markets in healthcare, along with the broader tradeoffs between quality and efficiency.
We start by discussing how information asymmetry, third-party payment, and limited competition make it difficult for the “invisible hand” to function in healthcare. Dr. Gupta then walks through his research on hospital readmission penalties, showing how financial incentives can improve care while also creating room for hospitals to game the metrics. We also explore the trade-offs behind hospital privatization and consolidation, including how efforts to make hospitals more efficient or profitable can affect prices, staffing, safety-net access, and patient outcomes. Finally, we examine private equity’s role in healthcare and what better regulation, transparency, and quality-linked incentives could look like in the future.